You are here

  • Home
  • Archive
  • Volume 97, Issue Suppl 1
  • O20.2 Ertapenem is non-inferior to ceftriaxone for the treatment of anogenital gonorrhea: the NABOGO randomized double blind non-inferiority trial

Article info

Article menu

Download PDFPDF

Late breakers
O20.2 Ertapenem is non-inferior to ceftriaxone for the treatment of anogenital gonorrhea: the NABOGO randomized double blind non-inferiority trial
Free

Authors

Citation

de Vries H, de Vries H, Jongen V, et al
O20.2 Ertapenem is non-inferior to ceftriaxone for the treatment of anogenital gonorrhea: the NABOGO randomized double blind non-inferiority trial
Sexually Transmitted Infections 2021;97:A63.

Publication history

  • First published July 6, 2021.
Online issue publication 
July 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.